No. 18-127
 
Title: Amgen Inc., et al., Petitioners
v.
Sanofi, et al.
Docketed: July 27, 2018
Linked with: 17A1262
Lower Ct: United States Court of Appeals for the Federal Circuit
   Case Numbers: (2017-1480)
   Decision Date: October 5, 2017
   Rehearing Denied: February 23, 2018
 
Proceedings and Orders
May 11 2018 Application (17A1262) to extend the time to file a petition for a writ of certiorari from May 24, 2018 to July 23, 2018, submitted to The Chief Justice.
Main Document Lower Court Orders/Opinions Other Proof of Service
May 14 2018 Application (17A1262) granted by The Chief Justice extending the time to file until July 23, 2018.
Jul 23 2018 Petition for a writ of certiorari filed. (Response due August 27, 2018)
Aug 27 2018 Brief amici curiae of Bristol-Myers Squibb Company, Morphosys AG, Bavarian Nordic A/S, and UCB Biopharma SPRL filed.
Sep 12 2018 DISTRIBUTED for Conference of 10/5/2018.
Sep 18 2018 Response Requested. (Due October 18, 2018)
Sep 20 2018 Motion to extend the time to file a response from October 18, 2018 to November 17, 2018, submitted to The Clerk.
Sep 20 2018 Motion to extend the time to file a response is granted and the time is extended to and including November 19, 2018
Nov 19 2018 Brief of respondents Sanofi, et al. in opposition filed.
Dec 04 2018 Reply of petitioners Amgen Inc., et al. filed. (Distributed)
Dec 05 2018 DISTRIBUTED for Conference of 1/4/2019.
Jan 07 2019 Petition DENIED.
Attorneys
Attorneys for Petitioners
Jeffrey Alan Lamken
Counsel of Record
MoloLamken LLP
The Watergate, Suite 500
600 New Hampshire Ave., N.W.
Washington, DC 20037

JLAMKEN@MOLOLAMKEN.COM
Ph: 2025562010
Party name: Amgen Inc., et al.


Attorneys for Respondents
Paul D. Clement
Counsel of Record
Clement & Murphy, PLLC
706 Duke Street
Alexandria, VA 22314

PAUL.CLEMENT@CLEMENTMURPHY.COM
Ph: (202) 742-8900
Party name: Sanofi, et al.


Other Attorneys
Jorge Alberto Goldstein
Counsel of Record
Sterne, Kessler, Goldstein & Fox, P.L.L.C.
1100 New York Avenue, NW
Washington, DC 20005

jgold@sternekessler.com
Ph: 202-772-8609
Party name: Bristol-Myers Squibb Company, Morphosys AG, Bavarian Nordic A/S, and UCB Biopharma SPRL